Saturday 16 January 2021
Home      All news      Contact us      RSS     
healtheuropa - 2 month ago

Trial shows positive results for reducing burden of stroke disability

Detailed results from an exploratory analysis of the THALES Phase III trial showed the medication Brilinta (ticagrelor) reduced the rate of the composite of disabling stroke or death. Results from the positive THALES Phase III trial have demonstrated that 90mg of Brilinta, used twice daily and taken with daily aspirin for 30 days, reduced the [ ] The post Trial shows positive results for reducing burden of stroke disability appeared first on Health Europa.


Latest News
Hashtags:   

Trial

 | 

shows

 | 

positive

 | 

results

 | 

reducing

 | 

burden

 | 

stroke

 | 

disability

 | 

Sources